Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

10.93
-0.2100-1.89%
Post-market: 10.930.00000.00%19:30 EDT
Volume:199.42K
Turnover:2.21M
Market Cap:534.32M
PE:-3.41
High:11.60
Open:11.26
Low:10.76
Close:11.14
52wk High:14.53
52wk Low:2.22
Shares:48.89M
Float Shares:19.90M
Volume Ratio:0.63
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2084
EPS(LYR):-3.4309
ROE:-36.58%
ROA:-22.34%
PB:1.54
PE(LYR):-3.19

Loading ...

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 17

RA Capital Management Reports Purchase of Artiva Biotherapeutics Common Shares Worth $194,237.66

Reuters
·
Jul 15

Major Stake Boost Signals Growing Confidence in Artiva Biotherapeutics

TIPRANKS
·
Jun 30

RA Capital Management Reports $292,129 Artiva Biotherapeutics Common Share Purchase

Reuters
·
Jun 30

Artiva Biotherapeutics to join H.C. Wainwright Cell Therapy Virtual Conference fireside chat

Reuters
·
Jun 24

RA Capital Management reports USD 4.56 million Artiva Biotherapeutics common stock acquisition

Reuters
·
Jun 17

RA Capital Management acquires Artiva Biotherapeutics common shares worth $8.19 million

Reuters
·
Jun 12

Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV), MoonLake Immunotherapeutics (MLTX) and MBX Biosciences, Inc. (MBX)

TIPRANKS
·
Jun 09

Artiva Biotherapeutics Price Target Maintained With a $41.00/Share by Needham

Dow Jones
·
Jun 08

Needham Sticks to Its Buy Rating for Artiva Biotherapeutics, Inc. (ARTV)

TIPRANKS
·
Jun 08

Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026

TIPRANKS
·
Jun 08

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

GlobeNewswire
·
Jun 08

Major Investor Makes Bold Move Into Artiva Biotherapeutics Stock

TIPRANKS
·
May 29

GC Corp acquires USD 12.5 million of Artiva Biotherapeutics common shares

Reuters
·
May 29

Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

GlobeNewswire
·
May 28

Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Phreesia (PHR)

TIPRANKS
·
May 26

Artiva says AB-101 plus rituximab posts 71% ACR50 response in refractory RA study

Reuters
·
May 20

Artiva Biotherapeutics Announces Multiple Allonk® Data Presentations at Eular 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous Car T-Cell Therapy in Rheumatologic Diseases

THOMSON REUTERS
·
May 20

Artiva Biotherapeutics Announces Major Executive Leadership Transitions

TIPRANKS
·
May 19

Artiva Biotherapeutics Inc - Thad Huston to Separate as CFO Effective May 22, 2026 - SEC Filing

THOMSON REUTERS
·
May 19